AAV gene editing therapies (Homology Medicines)

N/A

Report date: 2025/03/14 16:40:28

Base Information

Drug NameAAV gene editing therapies (Homology Medicines)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemoglobinopathiesEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQ32 Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesQ32 Bio Inc
Inactive CompaniesNovartis Ag
Active IndicationsHemoglobinopathiesEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A